Identifying and addressing childhood exposure to violence in pediatric care
Assessing for and Intervening upon Early Childhood Violence Exposure in Pediatric Primary Care Settings
This study is looking at how we can better check for signs of violence in young kids during their doctor visits, especially for those under five, to help them grow up healthier and happier.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10948481 on NIH RePORTER |
What this research studies
This research focuses on the critical issue of childhood exposure to violence (CEV) and its impact on young children's development. It aims to implement routine assessments for CEV during pediatric primary care visits, particularly for children aged five and under, who are most vulnerable. The study will evaluate current practices, identify barriers and facilitators to effective assessment, and analyze how these assessments correlate with healthcare outcomes. By engaging healthcare providers, the research seeks to enhance the identification and intervention strategies for children affected by violence.
Who could benefit from this research
Good fit: Ideal candidates for this research include children aged 0-5 years who are receiving care in pediatric primary care settings.
Not a fit: Patients who are older than 21 years or those who do not have access to pediatric primary care services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and support for children exposed to violence, ultimately enhancing their health and developmental outcomes.
How similar studies have performed: Previous research has shown that implementing routine assessments for social risks in healthcare settings can lead to better health outcomes, indicating a promising approach in this area.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Bender Sweet, Anna Elisabeth — University of Washington
- Study coordinator: Bender Sweet, Anna Elisabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.